Executive Officers

Dr. Browne has more than 30 years of experience in the pharmaceutical industry across multiple disciplines including R&D, operations and business development. Most recently he was President and CEO of Phrixus Pharmaceuticals, where he raised venture funding for the company’s Phase II clinical trial in heart failure. Read full biography.

John E. Thompson, Ph.D.
Executive Vice President, Research and Development

Dr. Thompson was appointed the Company’s President and Chief Executive Officer in January 1999, and he continued in that capacity until September 1999 when he was appointed Executive Vice President of Research and Development. Read full biography.

Joel Brooks
Chief Financial Officer & Treasurer

Mr. Brooks was appointed Chief Financial Officer and Treasurer of the Company in December 2000. From September 1998 until November 2000, Mr. Brooks was the Chief Financial Officer of Blades Board and Skate, LLC, a retail establishment specializing in the action sports industry. Read full biography.

Richard Dondero
Vice President, Research and Development

Mr. Dondero was appointed our Vice President of Research and Development in July 2004. From July 2002 until July 2004, Mr. Dondero was a Group Leader in the Proteomics Reagent Manufacturing division of Molecular Staging, Inc., a biotech firm engaged in the measurement and discovery of new biomarkers. Read full biography.